We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Goldman Sachs Group Inc | NYSE:GS | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 7.85 | 1.87% | 427.90 | 428.53 | 419.64 | 420.23 | 2,322,677 | 00:49:51 |
From Apr 2019 to Apr 2024
Nobel Biocare Holding AG (NOBN.EB), a Switzerland-based maker of dental implants, is considering a sale of the company and is working with Goldman Sachs Group Inc. (GS) in the process, Bloomberg News reported Tuesday on its website, citing people familiar with the matter.
An unspecified number of private equity firms have held preliminary talks with Nobel Biocare on a possible deal, one person told Bloomberg.
Full story at: www.bloomberg.com/news/2014-07-29/nobel-biocare-said-to-mull-2-billion-dental-maker-sale.html
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Goldman Sachs Chart |
1 Month Goldman Sachs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
